Listed

XBiotech Inc.: Form 10-Q/A for the period ended Mar 31, 2015

Filed with the SEC on Jun 18, 2015 and accepted by EDGAR at Jun 18, 2015, 12:53 ET.

Share

Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2015-01-01 to 2015-03-31$6.8mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2015-01-01 to 2015-03-31−$8.2mus-gaap:OperatingIncomeLoss
Income tax3 months2015-01-01 to 2015-03-31$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2015-01-01 to 2015-03-31−$8.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2015-01-01 to 2015-03-31−$0.29us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow3 months2015-01-01 to 2015-03-31−$6.5mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2015-01-01 to 2015-03-31$571.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2015-03-31$52.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-03-31$53.8mus-gaap:AssetsCurrent
Total assetsAt period end2015-03-31$58.7mus-gaap:Assets
Current liabilitiesAt period end2015-03-31$3.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2015-03-31$3.8mus-gaap:Liabilities
Shareholders' equityAt period end2015-03-31$54.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001171843-15-003499. Last ingested by Listed: Nov 14, 2026, 18:14 ET. Listed shows no prices and gives no investment advice.